- Our pediatric Diabetes Program has been a pioneer in the study and use of automated insulin-delivery systems that are revolutionizing the field of type 1 diabetes care.
- Our philosophy focuses on taking care of the child and his or her family first.
- Our internationally renowned physicians are groundbreakers in both research and treatment of diabetes in children.
- Our Diabetes Program is a leader in the study of the artificial pancreas.
Although type 1 diabetes, also known as juvenile diabetes, can be a burdensome condition, it can be managed. Children with diabetes that is well-managed can enjoy full, active lives.
Juvenile diabetes is a chronic autoimmune disease in which the body’s immune system targets and destroys the insulin-producing beta cells in the pancreas. Insulin is needed to move sugar, or glucose, into the body’s cells, which use it for energy.
“Diabetes is an extremely serious condition, and even if people are taking their medications, they are still at risk for long-term complications,” says Stuart A. Weinzimer, MD, a Yale Medicine pediatric endocrinologist and a professor of pediatrics at Yale School of Medicine. “Even so, we have a lot of really wonderful tools that make it possible for people to get their blood sugars into target, and if you can achieve that, you really can have a very long and healthy life.”
In fact, Yale Medicine’s Diabetes Program for children has been a pioneer in the study and use of automated insulin-delivery systems that are revolutionizing the field of type 1 diabetes care.